Summary
We have analysed the pharmacokinetics ofα-human atrial natriuretic polypeptide (α-hANP) in healthy subjects, using a two-compartment open model following bolus intravenous injection. The plasma half-times for the fast and slow components were 1.7±0.07 min and 13.3±1.69 min respectively. V1 (the volume of the central compartment), Vz (volume of distribution) and Vss (volume of distribution at steady-state) were 5370±855 ml (89.5±14.3 ml·kg−1), 32000±4620 ml (533±77.0 ml·kg−1), and 11900±1530 ml (198±25.5 ml·kg−1) respectively. The mean plasma clearance was 1520±121 ml·min−1 (25.4±2.0 ml·min−1·kg−1.
References
de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 28: 89–94
Kangawa K, Matsuo H (1984) Purification and complete amino acid sequence ofα-human atrial natriuretic polypeptide. Biochem Biophys Res Commun 118: 131–139
de Bold AJ (1985) Atrial natriuretic factor: A hormone produced by the heart. Science 230: 767–770
Cantin M, Genest J (1985) The heart and the atrial natriuretic factor. Endocr Rev 6: 107–127
Needleman P, Adams SP, Cole BR, Currie MG, Geller DM, Michener ML, Saper CB, Schwartz D, Standaert DG (1985) Atriopeptins as cardiac hormone. Hypertension 7: 469–482
Nakao K, Sugawara A, Morii N, Sakamoto M, Suda M, Soneda J, Ban T, Kihara M, Yamori Y, Shimokura M, Kiso Y, Imura H (1984) Radioimmunoassay forα-human and rat atrial natriuretic polypeptide. Biochem Biophys Res Commun 124: 815–821
Sugawara A, Nakao K, Morii N, Sakamoto M, Suda M, Shimokura M, Kiso Y, Kihara M, Yamori Y, Nishimura K, Soneda J, Ban T, Imura H (1985)α-Human atrial natriuretic polypeptide is released from the heart and circulates in the body. Biochem Biophys Res Commun 129: 439–446
Sugawara A, Nakao K, Morii N, Sakamoto M, Horii K, Shimokura M, Kiso Y, Nishimura K, Ban T, Kihara M, Yamori Y, Kangawa K, Matsuo H, Imura H (1986) Significance ofα-human atrial natriuretic polypeptide as a hormone in man. Hypertension 8 [Suppl I]: 151–155
Morii N, Nakao K, Sugawara A, Sakamoto M, Suda M, Shimokura M, Kiso Y, Kihara M, Yamori Y, Imura H (1985) Occurrence of atrial natriuretic polypeptide in brain. Biochem Biophys Res Commun 127: 413–419
Wagner JG (1975) The two compartment open model. In: Wagner JG (ed) Fundamentals of clinical pharmacokinetics. The Hamilton Press, Hamilton, Illinois, pp 82–83
Yamaoka K, Tanigawara Y, Nakagawa T, Uno T (1981) A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharm Dyn 4: 879–885
Sakamoto M, Nakao K, Kihara M, Morii N, Sugawara A, Suda M, Shimokura M, Kiso Y, Yamori Y, Imura H (1985) Existence of atrial natriuretic polypeptide in kidney. Biochem Biophys Res Commun 128: 1281–1287
Richards AM, Nicholls MG, Ikram H, Webster MW, Yandle TG, Espiner EA (1985) Renal, hemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet 1: 545–548
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakao, K., Sugawara, A., Morii, N. et al. The pharmacokinetics ofα-human atrial natriuretic polypeptide in healthy subjects. Eur J Clin Pharmacol 31, 101–103 (1986). https://doi.org/10.1007/BF00870995
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00870995